First Time Loading...

Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC

Watchlist Manager
Cyclacel Pharmaceuticals Inc Logo
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
Watchlist
Price: 2.23 USD -10.44% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

CYCC Price Targets Summary
Cyclacel Pharmaceuticals Inc

There are no price targets for CYCC.
CYCC Lowest Forecast
Wall Street Target
Not Available
CYCC Average Forecast
Wall Street Target
Not Available
CYCC Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Cyclacel Pharmaceuticals Inc Competitors:
Price Targets
ARMP
Armata Pharmaceuticals Inc
228% Upside
W
300142
Walvax Biotechnology Co Ltd
39% Upside
ADAG
Adagene Inc
390% Upside
TLX
Telix Pharmaceuticals Ltd
2% Upside
ARMP
Armata Pharmaceuticals Inc
228% Upside
W
300142
Walvax Biotechnology Co Ltd
39% Upside
ADAG
Adagene Inc
390% Upside
TLX
Telix Pharmaceuticals Ltd
2% Upside
688363
Bloomage Biotechnology Corp Ltd
36% Upside
PROB
Probi AB
52% Upside
ALERS
Eurobio Scientific SA
113% Upside
J
600201
Jinyu Bio-Technology Co Ltd
5% Upside

Revenue
Forecast

Revenue Estimate
Cyclacel Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Cyclacel Pharmaceuticals Inc's revenue is -17%. The projected CAGR for the next 3 years is 618%.

-17%
Past Growth
618%
Estimated Growth
Estimates Accuracy
6%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Cyclacel Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Cyclacel Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-67%
Average Miss
What are analyst estimates?

See Also

Summary
CYCC intrinsic value, competitors valuation, and company profile.
DCF Valuation
CYCC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CYCC stock valuation using valuation multiples.
Wall Street Estimates
CYCC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CYCC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYCC's stock price target?
Not Available

CYCC doesn't have any price targets made by Wall Street professionals.

What is Cyclacel Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
618%

For the last 8 years the compound annual growth rate for Cyclacel Pharmaceuticals Inc's revenue is -17%. The projected CAGR for the next 3 years is 618%.

ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.